Back to today’s briefing

Story perspectives

Breakthrough Gene Editing Offers Hope for Rare Disorder

7/25/2025

28 4

Summary

Story summary

In a groundbreaking study, researchers at the Broad Institute and Jackson Laboratory have harnessed prime editing to rectify ATP1A3 mutations in mice suffering from alternating hemiplegia of childhood (AHC). This innovative approach not only alleviated symptoms but also boosted survival rates, igniting hope for a lasting cure and paving the way for future clinical trials in gene therapy for rare genetic disorders.

1 of 1

Story summary

In a groundbreaking study, researchers at the Broad Institute and Jackson Laboratory have harnessed prime editing to rectify ATP1A3 mutations in mice suffering from alternating hemiplegia of childhood (AHC). This innovative approach not only alleviated symptoms but also boosted survival rates, igniting hope for a lasting cure and paving the way for future clinical trials in gene therapy for rare genetic disorders.